You are here

  • Home
  • Archive
  • Volume 65, Issue Suppl 1
  • PTU-133 Effect of Eluxadoline on Abdominal and Bowel Symptoms Over Time in Phase 3 Clinical Trials in Patients with Irritable Bowel Syndrome with Diarrhoea (IBS-D)

Citation Tools

Article menu
Download PDFPDF
BSG 2016
PTU-133 Effect of Eluxadoline on Abdominal and Bowel Symptoms Over Time in Phase 3 Clinical Trials in Patients with Irritable Bowel Syndrome with Diarrhoea (IBS-D)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Harris L, Lucak S, Chang L, et al
PTU-133 Effect of Eluxadoline on Abdominal and Bowel Symptoms Over Time in Phase 3 Clinical Trials in Patients with Irritable Bowel Syndrome with Diarrhoea (IBS-D)
Gut 2016;65:A122-A123.